MiMedx Group (MDXG) Reports Q4 EPS of 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. ARM
4. BROS
5. QCOM
6. EXPE
7. FSLY
8. CPAY
9. FICO
10. PAYC

Go back to MiMedx Group (MDXG) Reports Q4 EPS of 5c

MiMedx Announces 2016 Record Results

February 23, 2017 7:30 AM EST

MARIETTA, Ga., Feb. 23, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, today announced its record results for the fourth quarter and full year ended December 31, 2016.

Full Year 2016 Highlights are:

Revenue is a 31% increase over full year 2015 revenue Revenue of $245.0 million within range of MiMedx guidance Wound... More